Cephapirin: in vitro antibacterial spectrum.
- 1 November 1971
- journal article
- Vol. 22 (5) , 904-8
Abstract
Cephapirin, a new semisynthetic cephalosporin derivative, was found to have an antibacterial spectrum similar to that of cephalothin. Staphylococcus aureus was inhibited by cephapirin concentrations of 0.09 to 12.5 mug/ml. S. epidermidis, S. viridans, S. pyogenes, and Diplococcus pneumonia isolates were inhibited by less than 1 mug/ml. The Enterococcus required a concentration of 25 mug of antibiotic per ml for inhibition. Approximately 65% of Escherichia coli, and all Klebsiella, indole-negative Proteus, and Salmonella strains tested were inhibited by the drug. Serratia, Pseudomonas, indole-positive Proteus, and Erwinia strains were highly resistant. Inoculum size was not an important factor in determining the level of sensitivity of S. aureus to cephapirin. The antibiotic does not appear to be significantly bound to serum protein. In vitro development of resistance to the drug was demonstrated with two isolates of S. aureus.This publication has 6 references indexed in Scilit:
- Cephalexin: Microbiological effects and pharmacologic parameters in manClinical Pharmacology & Therapeutics, 1969
- A Methicillin-Resistant Strain ofStaphylococcus aureusAnnals of Internal Medicine, 1967
- Cephaloridine activity in vitro and absorption and urinary excretion in normal young men.1966
- CEPHALOTHIN-NEW ANTIBIOTIC - PRELIMINARY CLINICAL + LABORATORY STUDIES1964
- Some experimental and clinical studies on cephalothinClinical Pharmacology & Therapeutics, 1963